Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07468513 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A non randomized observation study that is aiming to assess the safety and efficacy of high dose primaquine (1mg/kg per day over 7 days) among patients with intermediate (30-70%) G6PD activity and the safety and efficacy of weekly primaquine among patients who are g6Pd deficient (\<30% activity)
Trial Details
NCT Number NCT07468513
Lead Sponsor Menzies School of Health Research
Collaborators: Curtin University, University of Melbourne, Arba Minch University, Papua New Guinea Institute of Medical Research, Mahidol Oxford Tropical Medicine Research Unit, Oxford University Clinical Research Unit, Vietnam, Indonesia University
Conditions
(from sponsor)		 Vivax Malaria, G6PD Deficiency
Related terms Glucosephosphate Dehydrogenase Deficiency, Malaria, Vivax
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov